CASI Pharmaceuticals, Inc. - Ordinary Shares (CASIF)

CUSIP: G1933S101

Q4 2023 13F Holders as of 31 Dec 2023

Holder snapshot 7 signals
Share change
-68,714
Put/Call ratio
57%
SEC-reported price per share
$7.16
Number of holders
17
Value change
-$338,820
Number of buys
3
Open additional details 1 more signal available
Number of sells
9
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
40,791,726

Security key

G1933S101

Report period

Q4 2023

Institutions

17

Top holders

10

Ownership snapshot

Top reported holders of CASIF - CASI Pharmaceuticals, Inc. - Ordinary Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Wellington Shields Capita...
Disclosed value leader
Wellington Shields Capita...
Comparable rows
0/15
Latest evidence
30 Sep 2023
13F Highest disclosed value: $392,845 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Wellington Shields Capital Management, LLC has the largest disclosed position value at $392.8K.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Wellington Shields Capital Management, LLC's linked filing trail.
Disclosed position value Top 5
Wellington Shields Capital Manage... $392.8K
Wellington Shields & Co., LLC $189.9K
VANGUARD GROUP INC $82.9K
GEODE CAPITAL MANAGEMENT, LLC $56.9K
JANE STREET GROUP, LLC $56.6K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Wellington Shields Capital Management, LLC
13F
Company
13F
—
denominator unverified
$392,845
153,455 shares
— 30 Sep 2023
Wellington Shields & Co., LLC
13F
Company
13F
—
denominator unverified
$189,865
74,166 shares
— 30 Sep 2023
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$82,854
32,365 shares
— 30 Sep 2023
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$56,885
22,221 shares
— 30 Sep 2023
JANE STREET GROUP, LLC
13F
Company
13F
—
denominator unverified
$56,637
22,124 shares
— 30 Sep 2023
FRANKLIN TEMPLETON INC
13F
Company
13F
—
denominator unverified
$50,629
19,777 shares
— 30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
17
Shares
275,894
Rows available
17
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q2 2026 Across Filers

Q2 2026 holders
1
Q4 2023 holders
17
Holder diff
16
Investor Q2 2026 Shares Q4 2023 Shares Share Diff Share Chg % Q2 2026 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .